Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seiji Ueda

Showing results (71-80 of 124) with videos related to

Pageof 13
Sort By:
Clinical and Experimental Medicine|November 27, 2012
Serum asymmetric dimethylarginine levels are independently associated with procollagen III N-terminal peptide in nonalcoholic fatty liver disease patientsHideyuki Hyogo, Sho-Ichi Yamagishi, Sayaka Maeda, et al.
Pharmacological Research|May 5, 2009
Ezetimibe decreases serum levels of asymmetric dimethylarginine (ADMA) and ameliorates renal injury in non-diabetic chronic kidney disease patients in a cholesterol-independent mannerTsukasa Nakamura, Eiichi Sato, Nobuharu Fujiwara, et al.
Molecular Medicine (Cambridge, Mass.)|November 8, 2006
Oral adsorbent AST-120 decreases serum levels of AGEs in patients with chronic renal failureSeiji Ueda, Sho-ichi Yamagishi, Masayoshi Takeuchi, et al.
Nephrology (Carlton, Vic.)|November 9, 2010
Tissue level of advanced glycation end products is an independent determinant of high-sensitivity C-reactive protein levels in haemodialysis patientsMakio Nagano, Kei Fukami, Sho-Ichi Yamagishi, et al.
Pharmacological Research|August 12, 2009
Co-administration of ezetimibe enhances proteinuria-lowering effects of pitavastatin in chronic kidney disease patients partly via a cholesterol-independent mannerTsukasa Nakamura, Eiichi Sato, Nobuharu Fujiwara, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|November 21, 2013
Dialysate vascular endothelial growth factor is an independent determinant of serum albumin levels and predicts future withdrawal from peritoneal dialysis in uremic patientsTakuma Hazama, Kei Fukami, Sho-ichi Yamagishi, et al.
Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association|February 18, 2020
Analysis of the impact of spinopelvic radiographic parameters on the severity of cervical spondylotic myelopathyKen Ninomiya, Tateru Shiraishi, Ryoma Aoyama, et al.
Scientific Reports|December 19, 2018
Chronic intermittent hypoxia-mediated renal sympathetic nerve activation in hypertension and cardiovascular diseaseKeiko Takahashi, Seiji Ueda, Takashi Kobayashi, et al.
Journal of Diabetes Investigation|September 5, 2019
Circulating kidney injury molecule-1 as a biomarker of renal parameters in diabetic kidney diseaseTomohito Gohda, Nozomu Kamei, Takeo Koshida, et al.
Vascular Pharmacology|December 21, 2006
Pitavastatin inhibits lysophosphatidic acid-induced proliferation and monocyte chemoattractant protein-1 expression in aortic smooth muscle cells by suppressing Rac-1-mediated reactive oxygen species generationUtako Kaneyuki, Seiji Ueda, Sho-ichi Yamagishi, et al.
Pageof 13

Showing results (71-80 of 124) with videos related to

Sort By:
Pageof 13
Clinical and Experimental Medicine|November 27, 2012
Serum asymmetric dimethylarginine levels are independently associated with procollagen III N-terminal peptide in nonalcoholic fatty liver disease patientsHideyuki Hyogo, Sho-Ichi Yamagishi, Sayaka Maeda, et al.
Pharmacological Research|May 5, 2009
Ezetimibe decreases serum levels of asymmetric dimethylarginine (ADMA) and ameliorates renal injury in non-diabetic chronic kidney disease patients in a cholesterol-independent mannerTsukasa Nakamura, Eiichi Sato, Nobuharu Fujiwara, et al.
Molecular Medicine (Cambridge, Mass.)|November 8, 2006
Oral adsorbent AST-120 decreases serum levels of AGEs in patients with chronic renal failureSeiji Ueda, Sho-ichi Yamagishi, Masayoshi Takeuchi, et al.
Nephrology (Carlton, Vic.)|November 9, 2010
Tissue level of advanced glycation end products is an independent determinant of high-sensitivity C-reactive protein levels in haemodialysis patientsMakio Nagano, Kei Fukami, Sho-Ichi Yamagishi, et al.
Pharmacological Research|August 12, 2009
Co-administration of ezetimibe enhances proteinuria-lowering effects of pitavastatin in chronic kidney disease patients partly via a cholesterol-independent mannerTsukasa Nakamura, Eiichi Sato, Nobuharu Fujiwara, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|November 21, 2013
Dialysate vascular endothelial growth factor is an independent determinant of serum albumin levels and predicts future withdrawal from peritoneal dialysis in uremic patientsTakuma Hazama, Kei Fukami, Sho-ichi Yamagishi, et al.
Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association|February 18, 2020
Analysis of the impact of spinopelvic radiographic parameters on the severity of cervical spondylotic myelopathyKen Ninomiya, Tateru Shiraishi, Ryoma Aoyama, et al.
Scientific Reports|December 19, 2018
Chronic intermittent hypoxia-mediated renal sympathetic nerve activation in hypertension and cardiovascular diseaseKeiko Takahashi, Seiji Ueda, Takashi Kobayashi, et al.
Journal of Diabetes Investigation|September 5, 2019
Circulating kidney injury molecule-1 as a biomarker of renal parameters in diabetic kidney diseaseTomohito Gohda, Nozomu Kamei, Takeo Koshida, et al.
Vascular Pharmacology|December 21, 2006
Pitavastatin inhibits lysophosphatidic acid-induced proliferation and monocyte chemoattractant protein-1 expression in aortic smooth muscle cells by suppressing Rac-1-mediated reactive oxygen species generationUtako Kaneyuki, Seiji Ueda, Sho-ichi Yamagishi, et al.
Pageof 13